SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 30 filers reported holding SILENCE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $308,864 | -34.2% | 16,256 | -25.2% | 0.00% | – |
| Q1 2024 | $469,562 | -82.1% | 21,739 | -91.8% | 0.00% | -100.0% |
| Q3 2023 | $2,618,670 | +16.1% | 266,667 | -35.0% | 0.00% | – |
| Q2 2023 | $2,255,000 | -44.9% | 410,000 | -37.9% | 0.00% | -100.0% |
| Q1 2023 | $4,092,000 | -59.4% | 660,000 | -0.0% | 0.00% | -50.0% |
| Q4 2022 | $10,067,882 | +151913.9% | 660,189 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,623 | -15.3% | 660,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,821 | -100.0% | 660,000 | -31.7% | 0.00% | -50.0% |
| Q1 2022 | $18,350,000 | +1.1% | 965,815 | +27.1% | 0.00% | 0.0% |
| Q4 2021 | $18,156,000 | – | 760,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 500,214 | $9,504,066 | 9.16% |
| TCG Crossover Management, LLC | 3,295,350 | $62,611,650 | 6.52% |
| M28 Capital Management LP | 185,100 | $3,516,900 | 4.56% |
| Nextech Invest Ltd. | 952,400 | $18,095,600 | 3.04% |
| Lombard Odier Asset Management (USA) Corp | 2,405,998 | $36,759,464 | 2.72% |
| Redmile Group, LLC | 2,014,296 | $38,271,624 | 2.31% |
| Logos Global Management LP | 1,476,061 | $28,045,159 | 2.28% |
| 5AM Venture Management, LLC | 476,200 | $9,047,800 | 2.02% |
| Vivo Capital, LLC | 1,105,454 | $21,003,626 | 1.94% |
| First Turn Management, LLC | 537,338 | $10,209,422 | 1.66% |